Variant report
Variant | nsv874892 |
---|---|
Chromosome Location | chr2:113804997-113810121 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000136695 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs13398479 | chr2:113804997-113804998 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs371356046 | chr2:113805000-113805001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs558728492 | chr2:113805017-113805018 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs539601918 | chr2:113805044-113805045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs189976128 | chr2:113805053-113805054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs537918596 | chr2:113805054-113805055 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs555033563 | chr2:113805057-113805058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs575017995 | chr2:113805060-113805061 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs534641619 | chr2:113805071-113805072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs10179714 | chr2:113805118-113805119 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs182603414 | chr2:113805136-113805137 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs543782334 | chr2:113805163-113805164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs367668683 | chr2:113805177-113805178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs34645153 | chr2:113805229-113805230 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs113009521 | chr2:113805237-113805238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs545983924 | chr2:113805243-113805244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs150707817 | chr2:113805281-113805282 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs542843202 | chr2:113805312-113805313 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs34294724 | chr2:113805369-113805370 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs542271738 | chr2:113805385-113805386 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs553246913 | chr2:113805388-113805389 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs561959184 | chr2:113805408-113805409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs573132447 | chr2:113805419-113805420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs183506850 | chr2:113805423-113805424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs549817697 | chr2:113805467-113805468 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs188389852 | chr2:113805495-113805496 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs569958226 | chr2:113805500-113805501 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs193250801 | chr2:113805547-113805548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs185718194 | chr2:113805580-113805581 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs565815742 | chr2:113805620-113805621 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs534436293 | chr2:113805639-113805640 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs371798246 | chr2:113805650-113805651 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs554622045 | chr2:113805679-113805680 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs62157692 | chr2:113805784-113805785 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs721870 | chr2:113805806-113805807 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs201899565 | chr2:113805834-113805835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs34163794 | chr2:113805856-113805857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs139431105 | chr2:113805891-113805892 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs559095060 | chr2:113805894-113805895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs150060698 | chr2:113805903-113805904 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs147306531 | chr2:113805944-113805945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs546021077 | chr2:113805956-113805957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs544960024 | chr2:113806058-113806059 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs140901635 | chr2:113806111-113806112 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs6756735 | chr2:113806121-113806122 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs541958959 | chr2:113806125-113806126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs144786827 | chr2:113806138-113806139 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs530540748 | chr2:113806158-113806159 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs147908669 | chr2:113806192-113806193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs141598749 | chr2:113806214-113806215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Mowat-Wilson syndrome | 21572526 | CNVD |
Disorders of sex development | 21048976 | CNVD |
epilepsy | 18472482 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Ischaemic stroke | 16980335 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Nephronophthisis | 17901113 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 17699850 | CNVD |
Ovarian cancer | 17699850 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Myelofibrosis | 22110671 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:113804600-113805400 | Enhancers | Fetal Intestine Large | intestine |
2 | chr2:113804600-113805400 | Enhancers | Fetal Intestine Small | intestine |
3 | chr2:113805400-113805600 | Weak transcription | Fetal Intestine Small | intestine |
4 | chr2:113805400-113805800 | Weak transcription | Fetal Intestine Large | intestine |
5 | chr2:113805600-113806000 | Enhancers | Fetal Intestine Small | intestine |
6 | chr2:113805800-113806000 | Enhancers | Fetal Intestine Large | intestine |
7 | chr2:113806000-113808600 | Weak transcription | Fetal Intestine Large | intestine |
8 | chr2:113806000-113809000 | Weak transcription | Fetal Intestine Small | intestine |
9 | chr2:113808400-113808800 | Weak transcription | Right Atrium | heart |
10 | chr2:113808600-113811600 | Enhancers | Fetal Intestine Large | intestine |
11 | chr2:113809000-113809200 | Enhancers | Fetal Intestine Small | intestine |
12 | chr2:113809000-113809200 | ZNF genes & repeats | Right Atrium | heart |
13 | chr2:113809200-113809600 | Weak transcription | Fetal Intestine Small | intestine |
14 | chr2:113809400-113813800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
15 | chr2:113809600-113811200 | Enhancers | Fetal Intestine Small | intestine |